Subscribe To

Price Alert Latest News Economic Calendar News

CRWKF / Cranswick upgraded as avian flu worries overplayed says Jefferies

Cranswick has received a hefty price target upgrade from Jefferies, which sees avian flu issues under control and potential benefits from downtrading due to the cost of living squeeze. The US broker has upped its target by 17% to 3,670p and kept a buy rating, adding the recent interim results underpinned forecasts for the year. Read More

Demo Live Account See Partner Details

Content Topics

Cranswick

Upgraded

Avian

Worries

Overplayed

Says

Jefferies

Stock

CRWKF

Posted: Dec 6 2022, 08:21

Author Name: Proactive Investors

CRWKF News

By Proactive Investors
February 2, 2023

Cranswick reports accelerated revenue growth, keeps guidance unchanged

Cranswick PLC (LSE:CWK) said revenue growth accelerated in the third quarter as full-year guidance remains unchanged. All four product categories for

By Proactive Investors
December 6, 2022

Cranswick upgraded as avian flu worries overplayed says Jefferies

Cranswick has received a hefty price target upgrade from Jefferies, which sees avian flu issues under control and potential benefits from downtrading

By Proactive Investors
November 22, 2022

Cranswick revenues rise 12.4% but profits hit by product recall charge

Food producer Cranswick reported a healthy 12.4% increase in half-year revenues reflecting good control of what it described as “widespread cost inf

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.